Skip to search formSkip to main contentSkip to account menu

PRX 00023

Known as: PRX-00023, PRX00023 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
PRX-00023, a serotonin 1A receptor agonist, was designed to provide high potency and selectivity for its target. To assess the… 
2007
2007
: EPIX Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) is developing PRX-00023, an oral aryl piperazine 5-HT1A agonist… 
2007
2007
PRX‐00023 is a novel, nonazapirone 5‐HT1A agonist in clinical development for treatment of affective disorders. The objectives of… 
Review
2007
Review
2007
  • T. de Paulis
  • Current opinion in investigational drugs
  • 2007
  • Corpus ID: 35371886
EPIX Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) is developing PRX-00023, an oral aryl piperazine 5-HT1A agonist… 
Highly Cited
2006
Highly Cited
2006
We report the discovery of a novel, potent, and selective amidosulfonamide nonazapirone 5-HT1A agonist for the treatment of… 
2006
2006
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2005
2005
  • 2005
  • Corpus ID: 195160372